Phase 4 Lung cancer trials recruiting now
All Lung cancer trials, every phase
26
Phase 4 recruiting
Other phases for Lung cancer
Phase 4 Lung cancer trials
- A Randomized Controlled Trial Comparing Percutaneous CT-Guided Biopsy and Shape-Sensing Robotic-Assisted Bronchoscopy
- An Open-label, Single-arm Study of Prophylaxis for Datopotamab Deruxtecan (Dato-DXd) -Related Stomatitis in Eligible Patients With Metastatic or Inoperable Locally Recurrent Breast Cancer or Locally Advanced or Metastatic Epidermal Growth Factor Receptor-Mutated Non-small Cell Lung Cancer.
- Anesthesia and Non-small Cell Lung Cancer Recurrence
- Befotertinib Adjuvant Therapy in Stage IA2-IB NSCLC Patients
- Chemoradiotherapy With Surgery Followed by Consolidation Durvalumab
- Comparison of Standard Dose Alectinib to Alectinib in Adjusted Dose Based on Alectinib Bloodlevels
- Dabrafenib and/or Trametinib Rollover Study
- EBUS-TBNA vs Transbronchial Mediastinal Cryobiopsy for Adequacy of Next Generation Sequencing
- Effects of Ciprofol on Myocardial Injury After Non-cardiac Surgery in Video-Assisted Thoracoscopic Surgery
- Erector Spinae Block for Thoracic Surgery
- Improving Osimertinib Exposure and Cost-effectiveness Using Pharmacokinetic Boosting With Cobicistat
- Lung Nodule Detection Using Ultra-long FOV PET/CT
- Metronomic Oral Paclitaxel Plus PD-1/ PD-L1 Inhibitor Maintenance in Advanced Lung Cancer (PULSE Study)
- Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study
- Opioid Free Anaesthesia-Analgesia Strategy on Surgical Stress and Immunomodulation in Elective VATS-Lobectomy for NSCLC
- Oral Paclitaxel Solution With Immunotherapy and Concurrent SBRT as Neoadjuvant Treatment for Older Adults With NSCLC
- Osimertinib Combined With Chemotherapy in Patients Who Had Distant Recurrence After Adjuvant Osimertinib for EGFRm Resectable SIB-IIIA NSCLC.
- PROspective Master-protocol for Evaluation of Systemic THErapeutics in Elderly With Thoracic Malignancies
- Postoperative Radiotherapy for Postoperative N2 Metastases of NSCLC in the Immunotherapy Era (Phase II)
- Pralsetinib DDI Study in Patients With Advanced or Metastatic Solid Tumors
- Pre- Vs Postoperative Thromboprophylaxis for Liver Resection
- Remimazolam for Bronchoscopy in High-Risk Patients
- Statins to Prevent Cancer Associated Blood Clots
- Study on the Therapeutic Effect of Irinotecan Liposomes in Small Cell Lung Cancer
- The Effects of Using Different Anesthetics on the Prognosis of Primary Lung Tumors and Its Mechanism of Action
- Trilaciclib vs Placebo in Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC) Receiving Topotecan
Common questions
What does Phase 4 mean?
Is this list complete?
No. For the full record, search ClinicalTrials.gov.